Given the anti-inflammatory effects of adiponectin, it is plausible that lowered adiponectin levels may predispose to sepsis-related proinflammatory complications in states of obesity, diabetes, and insulin resistance. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.